We are live on ! Find out more
ONC

BeOne Medicines Ltd

192 hedge funds and large institutions have $6.65B invested in BeOne Medicines Ltd in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 32

140% more call options, than puts

Call options by funds: $50.8M | Put options by funds: $21.1M

117% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 30

56% more funds holding in top 10

Funds holding in top 10: 914 (+5)

33% more funds holding

Funds holding: 144192 (+48)

0.23% more ownership

Funds ownership: 5.95%6.18% (+0.23%)

15% less capital invested

Capital invested by funds: $7.84B → $6.65B (-$1.19B)

Holders
192
Holders Change
+48
Holders Change %
+33.33%
% of All Funds
4.28%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.31%
New
82
Increased
65
Reduced
30
Closed
32
Calls
$50.8M
Puts
$21.1M
Net Calls
+$29.6M
Net Calls Change
+$49.2M
Name Holding Trade Value Shares
Change
Change in
Stake
GIBU
101
Gulf International Bank (UK)
United Kingdom
$1.25M +$1.18M +8,900 New
Invesco
102
Invesco
Georgia
$1.22M -$294K -2,219 -20%
Canada Life
103
Canada Life
Manitoba, Canada
$1.21M +$1.19M +8,951 New
LS
104
Livforsakringsbolaget Skandia
Sweden
$1.14M +$1.07M +8,100 New
TCS
105
Texas Children's
Texas
$1.08M +$1.02M +7,682 New
MIOT
106
Massachusetts Institute of Technology
Massachusetts
$1.08M +$1.02M +7,669 New
Zurich Cantonal Bank
107
Zurich Cantonal Bank
Switzerland
$1.03M +$974K +7,343 New
PA
108
Profund Advisors
Maryland
$947K -$489K -3,689 -35%
Millennium Management
109
Millennium Management
New York
$939K +$142K +1,073 +19%
First Trust Advisors
110
First Trust Advisors
Illinois
$885K -$840K -6,333 -50%
FFM
111
Fullerton Fund Management
Singapore
$855K +$808K +6,093 New
ACI
112
AMP Capital Investors
Australia
$846K +$819K +6,177 New
OMC
113
Oasis Management Company
Cayman Islands
$842K
ERSOT
114
Employees Retirement System of Texas
Texas
$842K +$796K +6,000 New
Qube Research & Technologies (QRT)
115
Qube Research & Technologies (QRT)
United Kingdom
$814K +$769K +5,800 New
HSBC Holdings
116
HSBC Holdings
United Kingdom
$740K -$348M -2,623,145 -100%
D.E. Shaw & Co
117
D.E. Shaw & Co
New York
$737K +$535K +4,032 +329%
BNP Paribas Asset Management
118
BNP Paribas Asset Management
France
$718K +$695K +5,242 New
BCIM
119
British Columbia Investment Management
British Columbia, Canada
$715K +$676K +5,100 New
Envestnet Asset Management
120
Envestnet Asset Management
Illinois
$706K +$667K +5,031 New
Nomura Asset Management
121
Nomura Asset Management
Japan
$697K +$659K +4,970 New
SAM
122
Shell Asset Management
Netherlands
$639K +$604K +4,553 New
Jennison Associates
123
Jennison Associates
New York
$633K +$11.4K +86 +2%
Teacher Retirement System of Texas
124
Teacher Retirement System of Texas
Texas
$587K +$555K +4,185 New
VOYA Investment Management
125
VOYA Investment Management
Georgia
$555K +$525K +3,960 New

ONC Hedge Fund Activity: Q4 2018 in Review

192 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2018, worth a combined $6.65B — down 15% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new ONC positions and 32 closed out — a net gain of 50 holders — while 65 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $186M. The largest seller was Hillhouse Investment Management, cutting an estimated $589M.

  • 192 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2018, up from 144 in Q3 2018.
  • Funds reported $6.65B of BeOne Medicines Ltd stock for Q4 2018, down 15% quarter-over-quarter.
  • 82 funds opened new BeOne Medicines Ltd positions in Q4 2018 and 32 closed out, a net change of +50 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2018 was BlackRock, an estimated $186M added.
  • The largest BeOne Medicines Ltd seller in Q4 2018 was Hillhouse Investment Management, an estimated $589M sold.

Based on aggregated 13F filings for Q4 2018.